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Abstract 
The phosphorylation of (+) alpha tocopherol produces adhesive nanostructures that interact 
with oral biofilms to restrict their growth. The aim of this work was to understand if these 
adhesive (+) alpha tocopheryl phosphate (α-TP) nanostructures could also control macrophage 
responses to the presence of oral bacteria. The (+) α-TP planar bilayer fragments (175 nm ± 21 
nm) formed in a Trizma® / ethanol vehicle swelled when exposed to the cell lines (maximum 
stabilised size = 29 µm). The swelled (+) α-TP aggregates showed selective toxicity towards 
THP-1 macrophages (LD50 = 304 µM) compared to human gingival fibroblasts (HGF-1 cells; 
LD50 > 5 mM), and they inhibited heat killed bacteria stimulated MCP-1 production in both 
macrophages (control  57.3 ± 18.1 pg/ mL vs (+) α-TP 6.5 ± 3.2 pg/ mL) and HGF-1 cells 
(control 673.5 ± 133 pg/ mL  vs (+) α-TP - 463.9 ± 68.9 pg/ mL).  
 
 
 
 
 
 
 
Key words: Alpha tocopheryl phosphate, aggregate swelling, human gingival fibroblasts, 
human peripheral blood monocytes, selective toxicity, monocyte chemoattractant 1. 
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Background 
Macrophages perform a number of important regulatory functions in the human body1, 
but in several pathologies including, malignant tumours 2, inflammatory disease 3, metabolic 
disease 4, infections 5, and periodontitis 6, their dysfunction is thought to contribute to disease 
progression 7. Anti-cytokine therapies can act to counteract macrophage dysfunction, but their 
‘off-target’ side-effects render the currently available agents inappropriate for this indication 8. 
Macrophages are highly mobile and thus they are difficult to specifically target through 
traditional drug delivery approaches 9. However, their ability to actively recognise and 
phagocytose foreign material provides a potential route to specifically deliver agents into 
macrophages using bespoke drug carrier systems. 
One class of lipids that have the potential to be formed into materials that could target 
macrophages is the tocopherol lipids 10. In recent work a novel tocopherol analogue, (+) alpha 
tocopheryl phosphate (α-TP) was synthesised and was shown to form oral bio-retentive 
nanomaterials that disrupt biofilm growth 11. In the mouth the ionic phosphate moiety of α-TP 
interacts with simple electrolytes and this gives it the potential to swell and change shape 12, 
which could facilitate macrophage phagocytosis and release of the active from the nanomaterial 
structure. However, the ability of α-TP nanomaterials to selectively target macrophage 
responses in the mouth has yet to be tested. 
In the mouth, macrophages and their cytokine products play an important role, along 
with enzymes, in both periodontal soft tissue and jawbone destruction 13. As a consequence, 
macrophages and the cytokines that stimulate macrophage recruitment (e.g., MCP-114), have 
become targets in the search for new agents to improve oral health 15. Therefore, the aim of 
this work was to understand if (+) α-TP nanomaterials could be used to target macrophage 
dysfunction in the mouth. It was predicted that the surface charge and size of the aggregates 
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would influence their uptake into oral tissue, therefore three types of tocopherol aggregates 
were used in this study: (+) α-T, which was predicted to display a neutral surface, and two 
structural isomers of α-TP, the (+) isomer and (±) isomer of α-TP, both of which were predicted 
to be negatively charged in the mouth.  
Materials 
(+) α-T (type (VI, ~ 40%), phosphorous oxychloride (POCl3) (≥ 99%), tetrahydrofuran 
(THF) (anhydrous) (≥ 99.9%), triflouroacetic acid (TFA) (≥ 99%), (±) α-T (≥ 96%), Trizma® 
hydrochloride  (Tris(hydroxymethyl)aminomethane hydrochloride) (≥ 99%), (±) α-TP (≥ 
97%), chlorhexidine digluconate (CHX) (20% w/v aqueous solution), cetylpyridinium chloride 
monohydrate (CPC) (99.0-102%), Hanks Balanced Salt Solution (HBSS) (Cat No H6648), 2-
mercaptoethanol (99%), Dulbecco's Phosphate Buffered Saline (PBS) (cat No D8537), trypan 
blue (0.4%), Phorbol 12-myristate 13-acetate (PMA) (≥ 99%, film), trypsin-EDTA (0.25%) 
and TRI-Reagent® (Ambion) where purchased from sigma Aldrich, UK. Hexane by fractions, 
absolute ethanol isopropanol, dimethyl sulfoxide (DMSO), disodium hydrogen phosphate (≥ 
99%), monosodium dihydrogen phosphate (≥ 99%), hydrochloric acid, sodium hydroxide, 
heat-inactivated Fetal Bovine Serum (FBS), penicillin G-streptomycin, MagMax™-96 for 
Microarrays Kit (Ambion, AM1839), High-Capacity RNA-to-cDNA™ Kit (Applied 
Biosystems) and TaqMan Universal PCR Master Mix (Applied Biosystems) were purchased 
from Fisher Scientific Ltd, UK. De-ionised water was used from laboratory supply. Dulbecco’s 
modified Eagle’s medium (DMEM) (ATCC 30-2002) cell culture medium and HGF-1 (ATCC 
CRL-2014) cells were purchased from the American Type Culture Collection (ATCC) (USA). 
Roswell Park Memorial Institute (RPMI) -1640 Medium (ATCC 30-2001) and the 
immortalised human peripheral blood monocyte cell line THP-1 (ATCC TIB-202) was sourced 
from LGC standards (UK). A colorimetric one step cell viability assay using a novel 
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tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine 
methosulfate; PMS) was purchased from Promega, USA. This has been previously used to 
assess toxicity of zinc oxide nanoparticles 16. Commercial enzyme-linked immunosorbent 
assays (ELISA’s) including human MCP-1/ CCL2, human IL-8 and human IL-6 max deluxe 
sets were purchased from Biolegend, USA. Disposable cuvettes (Macro, PMMA), tissue 
culture flasks (25 and 75 cm2 with ventilated caps) and 96-well plates where supplied by VWR 
(Germany). 
Methods 
(+) α-TP Synthesis  
(+) α-TP synthesis  used phosphorus oxychloride with triethylamine in anhydrous THF 
for 3 hours at room temperature as previously described 11. The pure product was obtained after 
C18 column chromatography. (+) α-TP was considered sterile due to the presence of 70% 
isopropanol in the purification step.   
Characterisation of (+) α-T, (+) α-TP, (±) α-TP aggregates in cell culture medium  
The size of the aggregates were monitored in cell culture media to mimic the gum tissue 
environment. The volume median diameters of (+) α-T, (±) α-TP and (+) α-TP were measured 
using a laser diffraction technique (Mastersizer X, version 2.15, Malvern Instruments, UK). 
The vitamin E derivatives (3 mM) dispersed initially in 20% ethanol, 80% water vehicles with 
150 mM Trizma®. Samples were diluted in cell culture medium (DMEM or RPMI without 
phenol red, FBS, or pen strep) to reach an obscuration ca 20%. The volume median diameters 
were recorded every 3 minutes for 15 minutes (N = 3).  
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Cultivation of gingival fibroblast cells and peripheral blood monocyte cells 
Two different cell lines HGF-1 and THP-1 important in gum disease were employed in 
the study 17,18. HGF-1 cells were cultured in DMEM, which included 10% FBS, and 1% of 
penicillin G-streptomycin (complete media A). The immortalised human peripheral blood 
monocyte cell line THP-1 was cultured in RPMI-1640 medium, which included 10% FBS, 1% 
of penicillin G-streptomycin and 50 μM 2-mercaptoethanol (antioxidant) (complete media B). 
Both cell lines were grown at 37°C in a 5% CO2, humidified atmosphere until HGF-1 cells 
reached confluence or until THP-1 monocytes reached 1x106 cell/ mL. HGF-1 cells were 
subcultured using trypsin-EDTA (0.25%) (5 mL) and reseeded at 50% cell density (i.e. 1 flask 
of confluent cells were split into 2 flasks). THP-1 monocytes were subcultured every 2-3 days 
(not allowed to exceed 1 x 106 cell/ mL) and were reseeded at 2 x 105 cells/ mL. HGF-1 and 
THP-1 cells used for experiments were between passages 3-8. 
Preparation of heat killed bacteria 
Oral heat killed bacteria was used to model the inflammatory environment found in 
vivo 19, 20. Human saliva (1 donor) was collected, formed into bacterial pellets, re-suspended in 
cell culture media (1 mL) (DMEM or RPMI-1640) and heat killed using a heating block (Grant, 
QBA1 series), UK) at 80 °C for 10 minutes. The heat killed bacteria was diluted to 0.18 OD620 
with cell culture medium under sterile conditions followed by a 1/100 dilution of the solution 
in cell culture medium to form the inflammatory stimuli. 
Determination of HGF-1 and THP-1 cell line viability 
The effects of (+)/ (±) α-TP, (+) α-T and heat killed human saliva bacteria, individually 
and in combination, were tested on HGF-1 and THP-1 cells. CHX and CPC were also tested 
on THP-1 macrophages as controls. To perform these assessments HGF-1 cells (passages 3-8) 
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were seeded (1 x104 cells/ well) 21 in 96 well microplates (100 µL/ well) and were incubated 
for 24 h at 37°C in a 5% CO2 atmosphere to allow for cell adhesion. The culture medium was 
then aspirated, and the cells were treated for 4 h with (+) α-TP (0.05, 0.5, 5, 50, 500, or 5000 
μM), (+) α-T (500 or 5000 μM) or (±) α-TP (500 μM) (100 μL/ well) after which the test 
samples were aspirated and the cells washed with HBSS (200 μL/ well). Either complete media 
or heat killed human bacteria from human saliva in complete media (1/100 dilution) was 
applied (100 μL/ well) and the samples were incubated for an additional 15 h at 37°C in a 5% 
CO2 atmosphere. The THP-1 monocytes were seeded (1 x104 cells/ well) with PMA (5 ng/ mL) 
to allow monocyte differentiation and subsequent cell adhesion in 96 well microplates and were 
incubated for 48 h at 37°C in a 5% CO2 atmosphere 22. The culture medium was aspirated, cells 
were washed with HBSS, and cultured in serum free media for 3 h. The cells were then treated 
for 2 h (the time was reduced from 4 h to reduce the time the cells were starved from FBS) 23 
with (+)  α-TP (0.05, 0.5, 5, 50, 500, or 5000 μM),  (±) α-TP (500 μM), (+) α-T (500 or 5000 
μM), CHX (50, 100, 150, 500, or 5000 μM) or CPC (0.05, 0.5, 5, 50, or 500 μM ) (100 μL/ 
well)  after which the test samples were aspirated, and the cells washed with HBSS (200 μL/ 
well). Either complete media or heat killed human bacteria from human saliva in complete 
media (1/100 dilution) were applied (100 μL/ well) and incubated for an additional 15 h at 
37°C in a 5% CO2 atmosphere. The 15 h supernatants were removed and used for ELISA assays 
and fresh complete media (100 μL) was added to the wells containing the colorimetric MTS 
tetrazolium compound (20 μL). Plates were then incubated at 37°C in a 5% CO2 atmosphere 
for 4 h after which time absorbance’s at 490 nm (iEMS Incubator/Shaker, Thermo Scientific, 
UK) were measured with reference subtractions at 650 nm. Untreated control cells were 
assigned a value of 100% viability (negative control), cell treated with 1% triton X (dispersed 
in cell culture media) were assigned a value of 0% viability (positive control). All the other 
conditions were compared to the controls using equation 1 were ABS is the corrected 
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absorbance’s. Results are expressed as means ± standard deviations of triplicate assays from 
three different experiments. Lethal dose 50% (LD50) values were calculated using the dose 
response model in Origin 2016. 
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝐶𝐶𝑣𝑣𝑣𝑣𝑣𝑣 (%) =  𝐴𝐴𝐴𝐴𝐴𝐴𝑠𝑠𝑎𝑎𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚−𝐴𝐴𝐴𝐴𝐴𝐴𝑚𝑚𝑝𝑝𝑠𝑠𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑚𝑚 𝑐𝑐𝑝𝑝𝑐𝑐𝑝𝑝𝑐𝑐𝑝𝑝𝑚𝑚
𝐴𝐴𝐴𝐴𝐴𝐴𝑐𝑐𝑚𝑚𝑛𝑛𝑎𝑎𝑝𝑝𝑝𝑝𝑝𝑝𝑚𝑚 𝑐𝑐𝑝𝑝𝑐𝑐𝑝𝑝𝑐𝑐𝑝𝑝𝑚𝑚−𝐴𝐴𝐴𝐴𝐴𝐴𝑚𝑚𝑝𝑝𝑠𝑠𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑚𝑚 𝑐𝑐𝑝𝑝𝑐𝑐𝑝𝑝𝑐𝑐𝑝𝑝𝑚𝑚  𝑋𝑋 100        Equation 1 
Determination of cytokine secretion  
MCP-1, IL-6 and IL-8 expression were measured in the selected cell lines in response 
to heat killed bacteria and this was repeated in the presence of the tocopherols in order to assess 
their anti-cytokine effects 24. Enzyme Linked Immunoassay (ELISA) kits were used to quantify 
the protein concentrations of MCP-1, IL-8 and IL-6 produced in the microplate cell 
supernatants according to the manufacturer’s protocols. Preliminary experiments showed that 
there was no detectable MCP-1 in the heat killed bacteria applied to the cells and hence the 
detected MCP-1 was solely generated from the HGF-1 cells. The test solutions at a 
concentration of 500 μM were not toxic against HGF-1 cells and hence this concentration was 
selected to assess their effect on MCP-1 release. 
mRNA expression assay 
mRNA transcript expression assays were performed using q-PCR on HGF-1 cells to 
understand how MCP-1, IL-8 and IL-6 expression was being regulated in the presence and 
absence of the three different tocopherol aggregates. The HGF-1 cells were cultured and treated 
using the same method as the cell viability assay with the exception that after the 15 h 
incubation with the inflammatory stimuli supernatants were removed, the cells washed with 
PBS (100 µL/ well) and then harvested with TRI-Reagent® (100 μL/ well). Cell treatments 
groups were in quintuplet and were combined in micro centrifuge tubes (500 µL, 50,000 cells) 
(N = 3).  The total RNA was extracted using MagMax™-96 for Microarrays Kit. RNA was 
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quantified using the NanoDrop (Thermo Scientific, UK). RNA integrity was analysed using 
the Bioanalyzer (Agilent, UK). A 50 ng aliquot of RNA per sample was reverse transcribed to 
cDNA using High-Capacity RNA-to-cDNA™ Kit. Expressions of MCP-1, IL-6 and IL-8 were 
analysed using probes from the Universal Probe Library (UPL, Roche). Actin beta (ACTB), 
Selenocysteine lyase (SCLY) and tRNA-yW synthesizing protein 1 homolog (TYW1) were 
used as reference genes (for primer sequence and probe selection, see supplementary material, 
Tables S1 and S2). Assays were designed following instructions from the Universal Probe 
Library Assay Design Centre 25. Quantitative PCR (qPCR) was performed using TaqMan 
Universal PCR Master Mix, following manufacturer’s protocol. Each 10 µL reaction contained 
0.2 µM forward primer and reverse primer and 0.1 µM UPL probe. cDNA was diluted 10-fold, 
and 4 µL of diluted cDNA was used per reaction. qPCR was performed on Applied Biosystems 
7900HT Real-Time PCR System under the following cycling conditions: 50°C for 2 minutes, 
95°C for 10 minutes, followed by 40 cycles of 95 °C for 15 seconds and 60 °C for 1 minute. 
Data was collected at the end of each cycle. 
Data analysis 
All data was expressed as their mean ± standard deviation (SD) at N = 3. The N numbers 
were independent experiments, each N number had three data points (three wells). Statistical 
analysis of the data was performed using Levine’s homogeneity test before statistical 
significance between the sample groups was assessed by one way analysis of variance 
(ANOVA) tests with post-hoc Tukey analysis in Origin 2016 (Silverdale scientific ltd, UK). 
Statistically significant differences were identified when p ≤ 0.05.  
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Results 
Aggregate characterisation in cell culture media   
Dynamic light scattering size analysis, zeta potential, atomic force microscopy (AFM) 
imaging and fluorescence spectroscopy measurements of the aggregates in 20% ethanol, 80% 
water, 150 mM Trizma®, pH 7.4 vehicles is reported in the supplementary material (See 
supplementary material, Figures S1-S4) 11, 12. The characterisation data showed (+) α-T 
produced spherical liposomes (563 ± 1 nm, -10.5 ± 0.2 mV), (+) α-TP produced planar bilayer 
fragments (175 nm ± 21 nm, -14.9 ± 3.5 mV) and (±) α-TP produced spherical liposomes (104 
nm ± 1.3 nm, -38.7 ± 7.0 mV) in an 20% ethanol 80% Trizma® buffer vehicle. The (+) α-TP 
nanomaterials size was shown to increase into the micron range when aliquoted into both the 
DMEM and RPMI cell culture media, with no statistically significant difference in the 
aggregate sizes between the two media (P > 0.05) (24.0 ± 4.9 µm and 28.52 ± 6.46 µm at 15 
min). The (+) α-T aggregates swelled in both DMEM and RPMI over a period of 15 min to 
sizes of 3.7 ± 0.7 µm and 3.8 ± 0.6 µm respectively, but unlike (+) α-TP this size did not change 
beyond the 15 min time point. The (±) α-TP isomer immediately swelled to a size of 35 ± 10 
µm in DMEM and 16 ± 9 µm in RPMI and then the size started to reduce upon further 
incubation (Figure 1 B).It was not possible to gain clear images of the swelled aggregates in 
the cell culture media.  
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Figure 1: The size changes of stereo-pure alpha tocopheryl phosphate ((+) Alpha TP) (3 mM) 
(A), (+) alpha tocopherol ((+) Alpha T) (3 mM) (A) and racemic alpha tocopheryl phosphate 
((±) Alpha TP) (B) in either Dulbecco's Modified Eagle's Medium (DMEM) or Roswell Park 
Memorial Institute (RPMI) 1640 medium to show the introduction of the phosphate group 
facilitates the swelling.. Data represented mean ± standard deviation, n = 3.  
 
HGF-1 cellular response to the tocopherol aggregates 
(+) α-TP was well tolerated by HGF-1 cells until a concentration of 5 mM (0.25% w/v) 
at which point the cell viability significantly dropped to 75.5 ± 7.9% (Figure 2). Both the (±) 
and the (+) α-TP isomer (500 µM) were found to have the same effects on cell viability (P > 
0.05), which suggested the stereochemistry was not a factor in the cell toxicity. At 5 mM (+) 
α-T did not reduce the cell viability (96.7 ± 6.1%), which showed that the addition of the 
phosphate group significantly increased the agents’ cell toxicity. 
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Figure 2: Human gingival fibroblast cell (HGF-1) viability upon tocopheryl application 
showing good tolerability to the test compounds. Cells treated with (+) alpha tocopheryl 
phosphate (alpha TP), (±) alpha TP or alpha tocopheryl (alpha T) diluted in Dulbecco's 
modified eagle's cell culture medium (without FBS) at 37 °C for 4 hours. Data represented 
mean ± standard deviation, n = 3. 
When treated with heat killed bacteria from human saliva, HFG-1 cells demonstrated a 
significant increase in secretion of MCP-1 (673.5 ± 133 pg/ mL, Figure 3A) as compared to 
the cells only treated with media (21.6 ± 15.6 pg/ mL). (+) α-T and (±) α-TP (500 μM) did not 
significantly inhibit MCP-1 production (α-T - 619 ± 63 pg/ mL, P > 0.05, (±) α-TP - 568 ± 107 
pg/ mL, P > 0.05). However, (+) α-TP (500μM) did significantly reduce MCP-1 production 
(463.9 ± 68.9 pg/ mL, P = 0.007). IL-8 (8601 ± 600 pg/ mL) and IL-6 (18310 ± 896 pg/ mL) 
were also produced in response the heat treated bacteria, but none of the tocopherol test agents 
were found to have an inhibitory effect on their production (See supplementary material, Figure 
S5).  
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Figure 3: Tocopherol inhibition of monocyte chemoattractant protein-1 (MCP-1) secreted 
from human gingival fibroblast cells showing (+) alpha TP was the only sample that produced 
a statistically significant reduction from the positive control. Cells pre-incubated with (+) 
alpha tocopheryl phosphate (alpha TP), (±) alpha TP or (+) alpha tocopherol (alpha T) 
samples for 4 h followed by 15 hours exposure to inflammatory stimuli. Data represented mean 
± standard deviation, n = 3. N.B. No change in cell morphology was noted by phase contrast.   
The pre-treatment of the HGF-1 cells with (+) α-TP before inflammatory stimulation 
did not significantly reduce the mRNA transcription of MCP-1, IL-6 or IL-8 compared to the 
heat killed bacteria treated cells (P > 0.05, see supplementary material, Figure S6).   
THP-1 macrophage cellular response to the aggregates 
 (+) α-TP was less well tolerated by the differentiated THP-1 monocytes (macrophages) 
compared to the HGF-1 cells (Figure 4). Macrophages treated with 500 µM of the (±) α-TP 
and (+) α-TP isomers were found only retain 7.7 ± 4.6 % (data not in figure) and 20.0 ± 4.4 %  
viability (Figure 4), respectively. The (+) α-TP LD50 against the macrophages was calculated 
to be 304 μM. As seen with the HGF-1 cells, (+) α-T (5 mM) was well tolerated by the THP-1 
macrophages. Both CHX and CPC, found in commercially available mouthwash products, 
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showed a lower LD50 value compared to (+) α-TP (Supplementary data, Figure S7), which 
suggested that (+) α-TP was better tolerated than CHX and CPC.  
 
 
 
 
 
 
 
Figure 4: (+) alpha tocopheryl phosphate toxicity to THP-1 macrophages generated an LD50 
value of 304 µM. Data represented mean ± standard deviation, n = 3. 
THP-1 macrophages treated with the negative control (media) produced 6.0 ± 2.9 pg/ 
mL of MCP-1 whilst the macrophages treated with heat killed bacteria generated 57.3 ± 18.1 
pg/ mL MCP-1 (Figure 5). (+) α-T (500 µM), which was not toxic to macrophages, was not 
found to inhibit MCP-1 generated from the THP-1 macrophages (55.3 ± 31.7 pg/ mL). Cells 
treated with (±) and (+) α-TP (500 µM), which were toxic to macrophages, resulted in very low 
levels of MCP-1 secretion (16.1 ± 5.1 pg/ mL for (±) isomer and 6.5 ± 3.2 pg/ mL for (+) 
isomer, p = 0.003) ((+) isomer, p > 0.05 with media control). Non-toxic concentrations of (±) 
or (+) α-TP did not inhibit MCP-1 production from the macrophage cells. 
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Figure 5: Tocopherol inhibition of monocyte chemoattractant protein (MCP-1) secretion from 
THP-1 macrophages related to cell viability showing that cell death inhibited MCP-1 release. 
Cells were pre-incubated with (+) alpha tocopheryl phosphate (alpha TP), (±) alpha TP or 
alpha tocopherol (alpha T). Data represented mean ± standard deviation, n = 3. N.B. No 
change in cell morphology was noted by phase contrast. 
Discussion 
The tocopherol nanomaterials tested in this work swelled when spiked into cell culture 
media. The different swelling profiles observed for the nanomaterials in the DMEM and RPMI 
fluids was thought to be a consequence of the media composition. The iron, which was only 
present in the DMEM, was identified as the most likely component to explain the differential 
behaviour, as it is known to interact with phosphorylated compounds 26. In both media the 
swelling of the nanomaterials was attributed to a transition of the lipid aggregates to multi-
lamella liposomes due to the change of ionic strength in the dispersion media 11. An alternative 
explanation to the observed size changes was that the nanomaterials were aggregating. 
However, this was thought to be unlikely as the dispersions changed size with a high degree of 
reproducibility, which is not common in aggregated systems 27. Unlike macrophages, non-
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viability 
100% 
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phagocytic cells are unlikely to internalise the micron sized carriers, hence the changes in 
nanomaterial characteristics in physiological fluids were thought to be beneficial for 
macrophage targeting. This hypothesis was supported by the cell cytotoxicity and cytokine 
suppression data discussed further below.  
The (+) α-TP reduced MCP-1 production by HGF-1 cells exposed to heat killed bacteria 
by approximately 32%. In the literature there does not seem to be a report that has previously 
shown that α-TP can suppress MCP-1 release. The anti-inflammatory agent, Bindarit, which 
has some structural similarities to α-TP has previously been shown to selectively inhibit MCP-
1 through the inhibition of MCP-1 mRNA, but in this work (+) α-TP was found not to inhibit 
mRNA transcript expression. From the lack of MCP-1 mRNA inhibition it could be deduced 
that (+) α-TP influenced post mRNA transcription activity such as protein synthesis or cellular 
protein secretion inhibition. However, because the cell signalling pathways for the heat treated 
saliva induced cytokine release from HGF-1 cells has not been well established the (+) alpha-
TP mechanism of action was not investigated further 28 because this would require the use of 
both pharmacological inhibitors and an investigation of the phosphorylation signals of MAPK 
to investigate the IL-6, IL-8 and MCP-1 release and then western blot analysis to look for 
protein expression changes, which we considered to be outside the scope of the current paper. 
It was surprising that all the tocopherols used in this work did not inhibit cytokine 
release from the cell lines because (+) α-T has previously been shown to have anti-
inflammatory effects 29,30,31. In addition, (+) α-T has been observed to inhibit IL-6 from HGF-
1 cells in the literature 32. However, in previous work LPS from P. gingivalis was used to induce 
the cytokine and in this study was heat killed bacteria from human saliva was used. It is possible 
that the tocopherols inhibit cytokine production on the LPS stimulation pathway and not other 
salivary inflammatory stimuli pathways. 
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The selective α-TP toxicity and subsequent reduction in MCP-1 secretion from THP-1 
macrophages was thought to be a function of the nanomaterial swelling. The most selective of 
the aggregates in terms of α-TP toxicity and MCP-1 suppression was (+) α-TP followed by (±) 
α-TP then (+) α-T, which was not toxic and did not supress MCP-1. This rank order aligned to 
the sizes of the aggregates when presented to the cells. This could, at least in part, be a 
consequence of greater internalisation of the larger aggregates due to more material volume 
being phagocytised by individual macrophages 33. Selective macrophage toxicity of α-TP was 
thought to be desirable for the treatment of the chronic inflammatory phase of periodontal 
disease as it could control the macrophage burden and shorten the immune response 34. 
However, it is not desirable to kill all macrophages as they perform a beneficial role of 
engulfing microbes and preventing the spread of systemic infection. In this aspect it was 
promising that even though (+) α-TP showed selective toxicity to the macrophages it was still 
found to be less toxic (lower LD50 values) than two commercially used antimicrobial agents 
CHX and CPC; suggesting that it was capable of regulating macrophage accumulation without 
complete depletion.  
Conclusion 
Mild and moderate periodontitis affects the majority of the adult global population with 
10.5 - 12% of the population affected by severe periodontitis making it the sixth most prevalent 
condition in 2010 35. However, at present, sub-antimicrobial dose doxycycline is the only agent 
that has been approved for human use that inhibits the gingival inflammatory process, the cause 
of the destructive elements of this disease 36. (+) α-TP has previously been shown to be tooth 
adherent, substantive, and capable of reducing the oral microbial burden 11, 12. In this study the 
swelling of (+) α-TP nano-sized aggregates was shown to have an anti-inflammatory effect on 
macrophages by selective macrophage toxicity thereby reducing MCP-1 generation. This effect 
would then dampen excessive macrophage burden and therefore reduce gingival destruction 
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making this compound an attractive prospect for development as a multifunctional agent to 
improve oral health.  
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